Jump to content

20250188166. Il-18 Polypeptides (BRIGHT PEAK THERAPEUTICS AG)

From WikiPatents

IL-18 POLYPEPTIDES FUSED TO IMMUNE CELL ANTIGEN SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

Abstract: the present disclosure relates to fusion immunocytokines comprising antibodies or antigen binding fragments specific for immune cell associated antigens, such as pd-1, and il-18 polypeptides. also provided herein are methods of treatment with and methods of manufacture of such fusion immunocytokines.

Inventor(s): Vijaya Raghavan PATTABIRAMAN, Bertolt KREFT, Arnaud GOEPFERT, Olivier BORNERT, Jean-Philippe CARRALOT, Kea MARTIN

CPC Classification: C07K16/2827 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250188166


Cookies help us deliver our services. By using our services, you agree to our use of cookies.